191 related articles for article (PubMed ID: 8206938)
1. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein.
Tayeh MA; Olson ST; Shore JD
J Biol Chem; 1994 Jun; 269(23):16318-25. PubMed ID: 8206938
[TBL] [Abstract][Full Text] [Related]
2. The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain.
Hasan AA; Cines DB; Zhang J; Schmaier AH
J Biol Chem; 1994 Dec; 269(50):31822-30. PubMed ID: 7989355
[TBL] [Abstract][Full Text] [Related]
3. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein.
Nishikawa K; Shibayama Y; Kuna P; Calcaterra E; Kaplan AP; Reddigari SR
Blood; 1992 Oct; 80(8):1980-8. PubMed ID: 1391955
[TBL] [Abstract][Full Text] [Related]
4. The kinin released from high molecular weight-kininogen is responsible for inflammatory exudation in rats: detection of kinin-free-kininogen in the exudate by immunoblot analysis.
Fujie H; Hayashi I; Oh-ishi S
Life Sci; 1993; 53(22):1691-701. PubMed ID: 8231650
[TBL] [Abstract][Full Text] [Related]
5. Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein.
Mashiko H; Miyamoto K; Takahashi H
Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):647-56. PubMed ID: 9854812
[TBL] [Abstract][Full Text] [Related]
6. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
Meloni FJ; Gustafson EJ; Schmaier AH
Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
[TBL] [Abstract][Full Text] [Related]
7. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
8. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
Page JD; Colman RW
J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human high molecular weight kininogen digestion by plasma kallikrein and by plasmin. A revised method of purification of high molecular weight kininogen.
Kleniewski J; Donaldson VH
J Lab Clin Med; 1987 Apr; 109(4):469-79. PubMed ID: 2950194
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1.
Dobó J; Major B; Kékesi KA; Szabó I; Megyeri M; Hajela K; Juhász G; Závodszky P; Gál P
PLoS One; 2011; 6(5):e20036. PubMed ID: 21625439
[TBL] [Abstract][Full Text] [Related]
11. Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains.
Müller-Esterl W; Rauth G; Lottspeich F; Kellermann J; Henschen A
Eur J Biochem; 1985 May; 149(1):15-22. PubMed ID: 2581778
[TBL] [Abstract][Full Text] [Related]
12. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
Etscheid M; Beer N; Fink E; Seitz R; Johannes D
Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
Reddigari SR; Kaplan AP
Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
[TBL] [Abstract][Full Text] [Related]
15. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
17. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
Wiggins RC
J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
19. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
[TBL] [Abstract][Full Text] [Related]
20. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
